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Abstract 
Background: The purpose of this study was to evaluate the 3-year visual outcomes in mild-to-moderate 
myopic patients with thin corneas who underwent photorefractive keratectomy (PRK) with or without 
mitomycin C (MMC). 
Methods: Thirty myopic eyes with a mean spherical equivalent (SE) of −3.76 ± 1.72 (−6.50 to −1.25) diopter 
(D) and a mean corneal thickness of 486.03 ± 11.93 (452-499) µm at the thinnest point underwent PRK. MMC 
was used if they had > 4.0 D myopia. All surgeries were performed with the VISX STAR S4 Excimer Laser 
(Abbott Medical Optics, Abbott Park, Illinois, USA). 
Results: Uncorrected visual acuity showed a significant improvement 3 years after surgery when compared to 
baseline and reached 0.01 ± 0.04 LogMAR (P < 0.001). Best-corrected visual acuity was 0.00 ± 0.01 LogMAR 
preoperatively and did not change significantly postoperatively. Spherical (P < 0.001) and cylindrical  
(P < 0.001) error significantly decreased. Manifest refraction SE showed a significant decrease when compared 
to before the operation and reached −0.08 ± 0.16 D (P < 0.001). At 3 years, mesopic contrast sensitivity was 
not significantly different from baseline at any spatial frequency. Vertical coma showed a significant decrease 
and reached −0.10 ± 0.27 µm (P = 0.004). Total coma (P < 0.001), spherical aberration (P < 0.001), and total 
high order aberrations (P < 0.001) also increased significantly. 
Conclusions: Based on the 3-year results, PRK (+MMC in patients with SE > 4.0 D) is a safe, effective, and 
predictable treatment option for mild-to-moderate myopic patients whose minimum corneal thickness is < 500 µm. 
© 2017 Tehran University of Medical Sciences. All rights reserved. 
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Introduction 
Different methods such as photorefractive keratectomy 
(PRK), laser in situ keratomileusis (LASIK), and 
intraocular refractive procedures are used to correct 
refractive errors. Due to the risk of post-LASIK ectasia 
(1-3), PRK is the preferred method for patients with thin 
corneas (4-6). However, there are reports of refractive 
regression (6) and complications such as corneal ectasia 
(7) following PRK, which prompted us to evaluate long-
term PRK results. By the end of the 1st year after PRK 
(8), we observed an improved uncorrected visual acuity 
(UCVA), decreased refractive error, better contrast 
sensitivity (CS) in two spatial frequencies of 6 and 12 
cycle/degree, and increased high-order aberrations 
(HOAs). In this report, we present the 3-year results of 
this procedure and compare them with the pre-operative 
and 1-year results. 
Materials and Methods 
As presented in the 1-year report (8), 30 eyes of 15 
patients (73.3% female) with a mean age of 29.47 ± 6.10 
(range: 20-41) years, mean spherical equivalent (SE) of 
−3.76 ± 1.72 (−6.50 to −1.25) D, and a mean minimal 
corneal thickness of 486.03 ± 11.93 (452-499) µm 
received PRK in this before-after interventional study. 
In accordance with clinic policy, mitomycin C (MMC) 
was used in PRK for patients with > 4.0 D myopia. The 
inclusion criterion was refractive stability for 18 
months before the surgery. Exclusion criteria were 
ocular pathology or history of ocular surgery. The 
patients discontinued wearing contact lenses 4 weeks 
before the surgery. The local review board reviewed 
and approved the study. The details of the study were 
explained to the patients before the operation, and 
written informed consents were obtained. 
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Pre- and post-operative examinations: UCVA and 
best-corrected visual acuity (BCVA) were evaluated 
with the Snellen chart, and manifest refraction SE 
(MRSE) was measured with a retinoscope (HEINE 
BETA 200, Germany). CS was assessed with the 
CVS1000 grating charts (VectorVision, Inc., 
Greenville, OH, USA) without dilation under mesopic 
(4 lux) conditions with best distance correction. 
Aberrations were measured with the Allegretto 
WaveLight Analyzer (WaveLight Laser Technologie 
AG, Germany) using the 6 mm setting of the device. 
Measurements were repeated and the best of three 
measurements was selected for each patient. Among 
aberrometry indexes, C6 (trefoil), C7 (vertical coma), 
C8 (horizontal coma), root mean square (RMS) 
comatotal, C9 (trefoil), C12 spherical aberration (SA), 
and RMS HOAtotal (RMS HOAT) were extracted. The 
following formula was used to calculate RMS comatotal: 
2 2C7 C8  
Repeated measures analysis of variance was used to 
determine the 3-year changes of the indices. The 
correlation between two eyes was adjusted. Patients 
were grouped by baseline MRSE, and changes in 
different indices were compared between Group A  
(< −4.00 D, n = 12 eyes) and Group B (≥ 4.00 D,  
n = 18) using independent sample t-test. 
Surgical technique: After topical anesthesia with 
proparacaine hydrochloride ophthalmic solution 0.5%, 
the corneal epithelium was mechanically scraped with 
a blunt spatula and no alcohol. VISX STAR S4 
Excimer laser (Abbott Medical Optics, Abbott Park, 
Illinois, USA) software version 5.30 was used for 
ablation (target fluence: 160 mJ/cm2, laser pulse rate: 
10.0 Hz). The selected ablation zone in all patients was 
6.0 mm with a blend zone. In eyes with > 4.0 D 
myopia, after laser irradiation, a sponge soaked in 
MMC 0.02% was applied on the ablated stroma for 10 
seconds per diopter of correction and then irrigated 
with 30cc of sterile balanced saline solution. A 
bandage contact lens (Air Optix, Ciba Vision) was 
applied on the eye at the end of the procedure.  
The post-operative regimen included levofloxacin 
eye drops 5 mg/ml and betamethasone 0.1% four times 
daily and preservative-free artificial tears (hypromellose, 
preservative free) as required. Voltaren was prescribed 
every 6 hours for 24 hours to decrease inflammation. 
The contact lens was removed and levofloxacin was 
discontinued upon reepithelialization, but betamethasone 
and artificial tears were continued for another 2 weeks. 
After that, fluorometholone ophthalmic suspension 0.1% 
was prescribed to be tapered over a 2-month course. 
Examinations were performed daily until complete 
epithelial healing was observed.  
 
Results 
At 3 years after surgery, one patient (two eyes) was lost 
to follow-up due to distance and complete satisfaction 
with vision. We detected no case of corneal ectasia at 
any time. 
UCVA had significantly improved by the end of  
3 years when compared to baseline (P < 0.001), but no 
significant change was observed when compared to  
1st-year results (P = 0.381). Three-year changes in 
UCVA were not significantly different between Groups 
A and B (P = 0.094). 
Pre-operative BCVA was 0.00 ± 0.01 LogMAR with 
no significant change after the operation. The safety 
index (post-operative BCVA/pre-operative BCVA) and 
efficacy index (post-operative UCVA/pre-operative 
BCVA) were 1.01 ± 0.03 and 1.00 ± 0.03, respectively.  
Spherical error, cylindrical error, and MRSE 
showed a significant decrease at 3 years after versus 
before the operation (all P < 0.001), but all of them had 
no significant change after the first post-operative year 
(P = 0.425, P = 0.244, and P = 0.126, respectively). At 
3 years, all patients were within ± 0.5 D of 
emmetropia. Mean residual SE was not significantly 
different between Group A (−0.11 ± 0.20 D) and Group 
B (0.07 ± 0.14 D) (P = 0.398). Results in terms of 
UCVA, BCVA, spherical error, cylinder error, and 
MRSE are presented in table 1. 
Mesopic CS showed no statistically significant 
change in any spatial frequency compared to baseline, 
and we found no significant difference between Groups 
A and B either (all P > 0.050). Comparison of 3-year 
and 1-year results showed insignificant changes as well 
(Table 2). 
The decrease in vertical coma was significant at  
3 years compared to baseline (P = 0.004) and 
borderline significant when compared to 1-year results 
(P = 0.065). 
 
Table 1. Changes of visual acuity and refraction following PRK in myopic thin cornea patients 
Variables Baseline 1 year after surgery 3 years after surgery P-value* 
Number of eyes 30 30 28  
UCVA (logMAR) 1.29 ± 0.55 0.00 ± 0.02 0.01 ± 0.04 < 0.001 
BCVA (logMAR) 0.00 ± 0.01 0.00 ± 0.02 0.01 ± 0.03 NA 
Spherical error (diopter) −3.31 ± 1.87 0.04 ± 0.15 0.02 ± 0.10 < 0.001 
Cylinder error (diopter) −0.71 ± 0.65 −0.20 ± 0.31 −0.14 ± 0.20 < 0.001 
MRSE (diopter) −3.76 ± 1.72 −0.03 ± 0.12 −0.08 ± 0.16 < 0.001 
*Based on paired t-test and comparison of pre-operative versus 3 years after surgery. UCVA: Uncorrected visual acuity;  
BCVA: Best-corrected visual acuity; MRSE: Manifest refraction spherical equivalent; PRK: Photorefractive keratectomy 
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Table 2. Changes in mesopic CS following PRK in myopic thin cornea patients 
Variables Pre-operative 1 year after surgery 3 years after surgery P-value* 
Number of eyes 30 30 28  
C3 (cycle/degree) 1.72 ± 0.09 1.75 ± 0.06 1.74 ± 0.09 0.745 
C6 (cycle/degree) 1.88 ± 0.08 1.94 ± 0.10 1.91 ± 0.11 0.343 
C12 (cycle/degree) 1.52 ± 0.14 1.65 ± 0.15 1.57 ± 0.13 0.184 
C18 (cycle/degree) 1.10 ± 0.16 1.12 ± 0.15 1.10 ± 0.16 0.924 
*Based on paired t-test and comparison of pre-operative and 3 years after surgery. CS: Contrast sensitivity; PRK: 
Photorefractive keratectomy 
 
At 3 years, total coma, total HOAs, and SA were 
significantly higher than baseline (P < 0.001), but no 
significant change was observed when compared to 1-
year results. Comparison of 3-year changes between 
Groups A and B indicated more SA increase in Group 
A compared to Group B (0.32 ± 0.15 vs. 0.18 ± 0.13 
µm, P = 0.018) as well as total HOAs (0.45 ± 0.14 vs. 
0.14 ± 0.20 µm, P < 0.001) (Table 3). 
 
Discussion 
The best surgical method for the correction of 
refractive errors depends on factors such as patients’ 
corneal thickness, anterior chamber depth, and severity 
of refractive error. A corneal thickness < 500 µm is a 
contraindication to LASIK due to the possibility of 
post LASIK ectasia (1,3,9,10). In these patients, PRK 
is a treatment option for the correction of myopia (11). 
A long-term study of surface ablation procedures, 
i.e., laser epithelial keratomileusis (LASEK) and PRK, 
showed acceptable results for the correction of myopia 
in patients with < 500 µm central corneal thickness 
(12). Compared to their results, we observed better 
outcomes, possibly owing to newer laser devices, 
modern surgical techniques, and the application of 
MMC in myopia > 4.0 D to prevent corneal haze (13). 
We detected no case of BCVA loss or refractive 
regression in our study, while 14 eyes (46.6%) 
developed late regression in the mentioned study (12). 
Comparison of the two groups with > or < 4.0 D 
showed good efficacy and safety for PRK-MMC even 
in thin cornea patients with > 4.0 D myopia and 
residual refraction in this group did not significantly 
differ from that in the group with < 4.0 D myopia. 
Reports on CS changes following PRK are 
inconsistent. Some studies have reported an 
improvement (14), some have reported a decrease 
(15,16), and most of them have reported no significant 
CS change (17-20) following PRK or LASEK in 
patients with a normal corneal thickness; this could be 
due to different follow-up durations and use of 
wavefront optimized methods. To the best of our 
knowledge, no study has evaluated mesopic CS 
changes following PRK in thin cornea patients. In our 
study, no significant change was observed 3 years later. 
This implies an unchanged visual quality and clarity 
following PRK in thin cornea patients as far as CS  
is concerned.  
Similar to other studies, we observed an increase in 
HOAs after the operation, but changes between the 1st 
and 3rd year after the operation were not significant, 
and HOAs remained stable. In a 10-year evaluation of 
patients with normal corneal thickness, Zhang et al. 
(21) reported increased HOAs following PRK, which 
then decreased considerably during 10 years after the 
operation and approximated pre-operative values. 
Longer follow-ups may be required to detect changes 
in thin cornea patients. However, it should be noted 
that increased HOAs following refractive surgery is a 
common finding due to reshaping the cornea to oblate 
(16,22).  
This is confirmed by the fact that SA and HOAs 
showed more increase in the group with higher myopia. 
Another point is that despite the increase in HOAs, 
mesopic CS had no significant change. This indicates 
that visual function is affected by not only aberrations 
but also neural processes that have an important role in 
the quality of vision. Vision-related quality of life 
questionnaires can be helpful to assess the impact of 
aberrations on visual quality. 
 
Table 3. Changes in higher order aberrations following PRK in myopic thin cornea patients 
Variables Pre-operative 1 year after surgery 3 years after surgery P-value* 
Number of eyes 30 30 28  
C6 trefoil (µm) −0.07 ± 0.11 −0.10 ± 0.14 −0.08 ± 0.16 0.874 
C7 vertical coma (µm) 0.07 ± 0.18 −0.03 ± 0.30 −0.10 ± 0.27 0.004 
C8 horizontal coma (µm) −0.03 ± 0.10 0.07 ± 0.37 0.05 ± 0.34 0.178 
Total coma (µm) 0.21 ± 0.08 0.40 ± 0.23 0.39 ± 0.22 < 0.001 
C9 trefoil (µm) 0.00 ± 0.10 −0.02 ± 0.10 0.01 ± 0.12 0.707 
C12 SA (µm) 0.01 ± 0.12 0.30 ± 0.17 0.26 ± 0.17 < 0.001 
RMS total HOAs (µm) 0.32 ± 0.07 0.58 ± 0.23 0.58 ± 0.23 < 0.001 
RMS: Root mean square; HOAs: Higher order aberrations; PRK: Photorefractive keratectomy; SA: Spherical aberration 
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In conclusion, based on our 3-year results, PRK 
(+MMC for patients with SE > 4.0 D) is a safe, 
effective, and predictable treatment option for mild-to-
moderate myopic patients with corneal thickness < 500 
µm. It improves visual acuity, corrects refractive 
errors, and does not affect the visual quality in high 
mesopic conditions. However, aberrations increase 
after the operation, but they decrease insignificantly 
after 1 year. 
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